Nutrisystem Inc (NTRI) 26.87 $NTRI NutriSystem Set to

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nutrisystem Inc (NTRI) 26.87 $NTRI

NutriSystem Set to Possibly Pullback After Yesterday's Rally of 3.78%
Comtex SmarTrend(R) - Tue Jun 28, 3:18PM CDT
NutriSystem (NASDAQ:NTRI) traded in a range yesterday that spanned from a low of $24.14 to a high of $25.05. Yesterday, the shares gained 3.8%, which took the trading range above the 3-day high of $24.55 on volume of 232,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NTRI: 26.87 (+0.84)

5 DuPont-Tested Juicy Stocks to Buy Now
Zacks Equity Research - Zacks Investment Research - Thu Jun 23, 7:49AM CDT
With the help of DuPont analysis, an investor could generate better returns.
FIX: 33.43 (+0.75), PETS: 19.24 (+0.28), MMI: 25.98 (+1.02), NTRI: 26.87 (+0.84), CVGW: 66.94 (+0.91)

5 Promising Picks Using DuPont Analysis
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 10:24AM CDT
DuPont analysis allows investors to assess which of the elements is dominant in any change in ROE.
THO: 71.19 (+1.30), PETS: 19.24 (+0.28), MMI: 25.98 (+1.02), NTRI: 26.87 (+0.84), WNC: 13.19 (+0.47)

Nutrisystem, Inc. to Present at the 36th Annual Piper Jaffray Consumer Conference
BusinessWire - Tue Jun 07, 7:00AM CDT
Nutrisystem, Inc. (NASDAQ: NTRI), a leading provider of weight management products and services, today announced that President and Chief Executive Officer Dawn Zier and Chief Financial Officer Michael Monahan will present at the 36th Annual Piper Jaffray Consumer Conference on Wednesday, June 15, 2016 at 1:10 p.m. ET. The conference is being held at The Lotte New York Palace in New York, NY.
NTRI: 26.87 (+0.84)

Nutrisystem Goes Country: Official Partner of the 2016 CMA Music Festival
BusinessWire - Mon Jun 06, 8:01AM CDT
Nutrisystem (NASDAQ:NTRI), a leading provider of weight management products and services, announced today that they are an official partner of the 2016 CMA Music Festival. In addition, legendary singer, entertainer, and Nutrisystem ambassador, Marie Osmond, will make an appearance on the CMA Close Up Stage inside Fan Fair X at the Music City Center.
NTRI: 26.87 (+0.84)

22.9% Return Seen to Date on SmarTrend NutriSystem Call (NTRI)
Comtex SmarTrend(R) - Fri Jun 03, 12:56AM CDT
SmarTrend identified an Uptrend for NutriSystem (NASDAQ:NTRI) on April 25th, 2016 at $21.76. In approximately 1 month, NutriSystem has returned 22.93% as of today's recent price of $26.75.
NTRI: 26.87 (+0.84)

Nutrisystem (NTRI): Moving Average Crossover Alert
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 9:53AM CDT
Are you a technical investor? If so, it may be time to consider Nutrisystem, Inc. (NTRI) for your portfolio
NTRI: 26.87 (+0.84)

5 Picks Based on DuPont for Exciting Returns
Zacks Equity Research - Zacks Investment Research - Mon May 23, 12:50PM CDT
The help of DuPont analysis, could lead to better returns.
PETS: 19.24 (+0.28), MMI: 25.98 (+1.02), NTRI: 26.87 (+0.84), SHI: 47.75 (+0.74), WNC: 13.19 (+0.47)

Is Nutrisystem (NTRI) a Great Growth Stock?
Zacks Equity Research - Zacks Investment Research - Fri May 20, 7:46AM CDT
Nutrisystem (NTRI) has a favorable Zacks Rank and is a fast-growing stock that is well positioned for future earnings growth.
NTRI: 26.87 (+0.84)

Nutrisystem Named Customer Service Department of the Year
BusinessWire - Thu May 19, 12:00PM CDT
Nutrisystem, Inc. (NASDAQ: NTRI), a leading provider of weight loss management products and services, was named the winner of a Stevie(R) Award in the Customer Service Department of the Year category in the 14th Annual American Business Awards.
NTRI: 26.87 (+0.84)

NutriSystem Has Returned 18.9% Since SmarTrend Recommendation (NTRI)
Comtex SmarTrend(R) - Thu May 19, 1:10AM CDT
SmarTrend identified an Uptrend for NutriSystem (NASDAQ:NTRI) on April 25th, 2016 at $21.76. In approximately 3 weeks, NutriSystem has returned 18.89% as of today's recent price of $25.87.
NTRI: 26.87 (+0.84)

The Zacks Analyst Blog Highlights: Walt Disney, Royal Caribbean Cruises, Dish Network, Nutrisystem and Mohawk Industries
Zacks Equity Research - Zacks Investment Research - Thu May 12, 8:30AM CDT
The Zacks Analyst Blog Highlights: Walt Disney, Royal Caribbean Cruises, Dish Network, Nutrisystem and Mohawk Industries
RCL: 68.38 (+1.59), MHK: 194.20 (+5.00), NTRI: 26.87 (+0.84), DIS: 99.62 (+1.21), DISH: 51.85 (+0.59)

Uptrend Call Working As NutriSystem Stock Rises 19.7% (NTRI)
Comtex SmarTrend(R) - Wed May 11, 1:35PM CDT
SmarTrend identified an Uptrend for NutriSystem (NASDAQ:NTRI) on April 25th, 2016 at $21.76. In approximately 2 weeks, NutriSystem has returned 19.72% as of today's recent price of $26.05.
NTRI: 26.87 (+0.84)

Forget Disney; Buy These 4 Consumer Discretionary Stocks
Swarup Gupta - Zacks Investment Research - Wed May 11, 10:21AM CDT
Other stocks in the consumer discretionary sector have however been posting impressive results.
RCL: 68.38 (+1.59), MHK: 194.20 (+5.00), NTRI: 26.87 (+0.84), DISH: 51.85 (+0.59)

Can the Rally in Nutrisystem (NTRI) Shares Continue?
Zacks Equity Research - Zacks Investment Research - Wed May 11, 9:33AM CDT
Nutrisystem, Inc. (NTRI) has been on the move lately as the stock has risen by 32.3% in the past four weeks, and it is currently trading well above its 20-Day SMA
NTRI: 26.87 (+0.84)

Is Nutrisystem an Incredible Momentum Stock? 3 Reasons Why NTRI Will Be Tough to Beat
Zacks Equity Research - Zacks Investment Research - Tue May 10, 7:26AM CDT
Nutrisystem (NTRI) is looking especially impressive right now and might be a great candidate for momentum-oriented investors in the near term
NTRI: 26.87 (+0.84)

Nutrisystem, Inc. to Present at the B. Riley & Co. 17th Annual Investor Conference
BusinessWire - Mon May 09, 3:05PM CDT
Nutrisystem, Inc. (NASDAQ: NTRI), a leading provider of weight management products and services, today announced that President and Chief Executive Officer Dawn Zier and Chief Financial Officer Michael Monahan will present at the B. Riley & Co. 17th Annual Investor Conference on Wednesday, May 25, 2016 at 3:30 p.m. PT (6:30 p.m. ET). The conference is being held at the Loews Hollywood Hotel in Hollywood, CA.
NTRI: 26.87 (+0.84)

Priceline and Glu Mobile slump, ICE and Zillow jump
AP - Wed May 04, 3:48PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq stock market:
BGFV: 9.85 (+0.35), NTRI: 26.87 (+0.84), CAR: 34.61 (+3.71), ZG: 36.86 (+0.61), GLUU: 2.35 (+0.05), Z: 36.16 (+0.71), TWX: 77.96 (+1.85)

Why NutriSystem Inc. Stock Soared 20%
Daniel Sparks, The Motley Fool - Motley Fool - Wed May 04, 12:54PM CDT
What: Shares of NutriSystem , a provider of weight management products and services, soared as high as 20.3% on Wednesday after the company reported better-than-expected results. The stock is up 14.1% at the time of this writing. Image...
NTRI: 26.87 (+0.84)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 364

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 157

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 160

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 147

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 170

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading

Top 5 Most Recently Viewed Articles

Genmab's Ongoing Share Buy-back Program Details and Impact

Updated Category News Views 119

Introduction to the Share Buy-back Program In a recent announcement, Genmab A/S (NASDAQ: GMAB) revealed that it has initiated an ambitious share buy-back program. This initiative aims to repurchase up to 2.2 million shares, which is a strategic step not just to reduce capital but also to fulfill commitments under the Restricted Stock Unit program. The company anticipates...

Continue Reading
Allego Strengthens Leadership with New Innovative CTO

Updated Category News Views 159

Allego Appoints Holger Riemenschneider as Chief Technology Officer Allego N.V. (NASDAQ: ALGO) has recently appointed Holger Riemenschneider as its Chief Technology Officer. This move is a significant step for the company, which has rapidly established itself as a leading name in the electric vehicle (EV) charging industry. With Holger on board, Allego is looking to...

Continue Reading
Exploring the Growth Drivers of Semiconductor Fabrication Software

Updated Category News Views 167

Understanding the Semiconductor Fabrication Software Market The Semiconductor Fabrication Software market is on the brink of significant transformation, with projections indicating a remarkable growth of approximately USD 984.91 million from 2024 to 2028. This growth is primarily fueled by the rising complexity of semiconductor designs in conjunction with the impact of...

Continue Reading
Ohmyhome Prepares to Share Exciting Q3 2024 Growth Insights

Updated Category News Views 45

Ohmyhome Set to Unveil Q3 2024 Growth Insights As a leading property technology platform, Ohmyhome Ltd. (NASDAQ: OMH) has established itself as a prominent player in the real estate market. The company specializes in offering comprehensive solutions ranging from brokerage, renovation, and management services for properties in the region. As consumers increasingly look for...

Continue Reading
Eli Lilly Prepares for Major Breast Cancer Data Presentation

Updated Category News Views 220

Introduction to Eli Lilly's Breast Cancer Initiatives At the upcoming San Antonio Breast Cancer Symposium (SABCS), Eli Lilly and Company (NYSE: LLY) is set to unveil groundbreaking data that enhances its portfolio in breast oncology. The symposium, running from December 9 to 12, serves as a platform for Lilly to highlight advancements in treatments for hormone...

Continue Reading